Bcl-2 and its homologues in the brain of patients with multiple sclerosis

Multiple Sclerosis

Volumn 10, Issue 2, 2004, Pages 176-181

  Banisor, Ileana ^a   Kalman, Bernadette ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Apoptosis; Molecular pathology; Multiple sclerosis

Indexed keywords

BETA 2 MICROGLOBULIN; GLUTATHIONE SYNTHASE; MESSENGER RNA; PROTEIN BAK; PROTEIN BCL 2; PROTEIN BCL XL; SCAVENGER; SUPEROXIDE DISMUTASE;

ADULT; ALZHEIMER DISEASE; APOPTOSIS; ARTICLE; BRAIN CORTEX; BRAIN REGION; CONTROLLED STUDY; CORRELATION ANALYSIS; FRONTAL LOBE; GENE EXPRESSION; GRAY MATTER; HUMAN; HUMAN CELL; HUMAN TISSUE; MULTIPLE SCLEROSIS; PROTEIN EXPRESSION; SENILE PLAQUE; SEQUENCE HOMOLOGY; WHITE MATTER;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BCL-2 HOMOLOGOUS ANTAGONIST-KILLER PROTEIN; BCL-X PROTEIN; BETA 2-MICROGLOBULIN; BRAIN CHEMISTRY; FRONTAL LOBE; GENE EXPRESSION; GLUTATHIONE SYNTHASE; HUMANS; MEMBRANE PROTEINS; MIDDLE AGED; MULTIPLE SCLEROSIS; PROTO-ONCOGENE PROTEINS C-BCL-2; SUPEROXIDE DISMUTASE;

EID: 16544367268     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1191/1352458504ms99oa     Document Type: Article

References (17)

1. Zettle UK, Kulhmann T, Brueck W. Bcl-2 expressing T lymphocytes in multiple sclerosis lesions. Neuropath Appl Neurobiol 1998; 24: 202-208.
2. Kuhlmann T, Glas M, zum Bruch C, Mueller W, Weber A, Zipp F et al. Investigation of bax, bcl-2, bcl-x and p53 gene polymorphisms in multiple sclerosis. J Neuroimmunol 2002; 129: 154-60.
3. Okuda Y, Okuda M, Bernard CC. The suppression of T cell apoptosis influenced the severity of disease during the chronic phase but not the recovery from the acute phase of experimental autoimmune encephalomyelitis in mice. J Neuroimmunol 2002; 131: 115-25.
4. DeBiasi RL, Kleinschmidt-deMasters BK, Richardson-Burns S, Tyler KL. Central nervous system apoptosis in human Herpes Simplex Virus and Cytomegalovirus encephalitis. J Inf Dis 2002; 186: 1547-57.
5. L levels correlate with T cell survival in multiple sclerosis. J Neuroimmunol 2002; 126: 213-20.
6. Seidi OA, Sharief MK. The expression of apoptosis-regulatory proteins in B lymphocytes from patients with multiple sclerosis. J Neuroimmunol 2002; 130: 202-10.
7. Sharief MK, Douglas M, Noori M, Semra YK. The expression of pro- and anti-apoptosis Bcl-2 family proteins in lymphocytes from patients with multiple sclerosis. J Neuroimmunol 2002; 125: 155-62.
8. Lucchinetti C, Bruck W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H. Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination. Ann Neurol 2000; 47: 707-17.
9. Peterson JW, Bo L, Mork S, Chang A, Trapp B. Transected neuritis, apoptotic neurons and reduced inflammation in cortical multiple sclerosis lesions. Ann Neurol 2001; 50: 389-400.
10. Vladimirova O, O'Connor J, Cahill A, Alder H, Butunoi C, Kalman B. Oxidative damage to DNA in plaques of MS brains. Mult Scler 1998; 4: 413-18.
11. Lu F, Selak M, O'Connor J, Croul S, Lorenzana C, Butunoi C et al. Oxidative damage to mitochondrial DNA and activity of mitochondrial enzymes in chronic active lesions of multiple sclerosis. J Neurol Sci 2000; 177: 95-103.
12. Ferrante RJ, Browne SE, Shinobu LA, Browling AC, Baik MJ, MacGarvey U et al. Evidence of increased oxidative damage in both sporadic and familial amyotrophic lateral sclerosis. J Neurochem 1997; 69: 2064-74.
13. Heales SJR, Bavies SEC, Bates TE, Clark JB. Depletion of brain glutathione is accompanied by impaired mitochondrial function and decreased N-acetyl aspartate concentration. Neurochem Res 1995; 20: 31-38.
14. Zagorski T, Dudek I, Berkan L, Mazurek M, Kedziora J, Chmielewski H. [Superoxide dismutase (SOD-1) activity in erythrocytes of patients with multiple sclerosis]. [Polish] Neurologia I Neurochirurgia Polska 1991; 25: 725-30.
15. Bonetti B, Pohl J, Gao YL, Raine CS. Cell death during autoimmune demyelination: effector but not target cells are eliminated by apoptosis. J Immunol 1997; 159: 5733-41.
16. Raine CS, Bonetti B, Cannella B. Multiple sclerosis: expression of molecules of the tumor necrosis factor ligand and receptor families in relationship to the demyelinated plaque. Rev Neurol 1998; 154: 577-85.
17. Kuhlmann T, Lucchinetti C, Zettl UK, Bitsch A, Lassmann H, Bruck W. Bcl-2-expressing oligodendrocytes in Multiple Sclerosis. GLIA 1999; 28: 34-39.